 | • レポートコード：GIR-105X05835 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ED治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ED治療の種類別市場規模（シルデナフィル、タダラフィル、その他）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ED治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly、Pfizer、Bayer、BaiYunShan General Factory、S.K. Chemicals、Teva Pharma、Dong-A ST、Metuchen Pharma、Seoul Pharma、CSBIO. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：シルデナフィル、タダラフィル、その他 ・用途別分析2016年-2026年：病院、ドラッグストア、その他 ・ED治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ED治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ED治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ED治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ED治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The ED Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global ED Treatment size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global ED Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
ED Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sildenafil
Tadalafil
Others
Market segment by Application can be divided into
Hospitals
Drugstores
Other
The key market players for global ED Treatment market are listed below:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 ED Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global ED Treatment Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global ED Treatment Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Other
1.4 Global ED Treatment Market Size & Forecast
1.4.1 Global ED Treatment Sales in Value (2016-2026))
1.4.2 Global ED Treatment Sales in Volume (2016-2026)
1.4.3 Global ED Treatment Price by Type (2016-2026) & (USD/Unit)
1.5 Global ED Treatment Production Capacity Analysis
1.5.1 Global ED Treatment Total Production Capacity (2016-2026)
1.5.2 Global ED Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 ED Treatment Market Drivers
1.6.2 ED Treatment Market Restraints
1.6.3 ED Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly ED Treatment Product and Services
2.1.4 Eli Lilly ED Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer ED Treatment Product and Services
2.2.4 Pfizer ED Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer ED Treatment Product and Services
2.3.4 Bayer ED Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 BaiYunShan General Factory
2.4.1 BaiYunShan General Factory Details
2.4.2 BaiYunShan General Factory Major Business
2.4.3 BaiYunShan General Factory ED Treatment Product and Services
2.4.4 BaiYunShan General Factory ED Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 S.K. Chemicals
2.5.1 S.K. Chemicals Details
2.5.2 S.K. Chemicals Major Business
2.5.3 S.K. Chemicals ED Treatment Product and Services
2.5.4 S.K. Chemicals ED Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Teva Pharma
2.6.1 Teva Pharma Details
2.6.2 Teva Pharma Major Business
2.6.3 Teva Pharma ED Treatment Product and Services
2.6.4 Teva Pharma ED Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Dong-A ST
2.7.1 Dong-A ST Details
2.7.2 Dong-A ST Major Business
2.7.3 Dong-A ST ED Treatment Product and Services
2.7.4 Dong-A ST ED Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Metuchen Pharma
2.8.1 Metuchen Pharma Details
2.8.2 Metuchen Pharma Major Business
2.8.3 Metuchen Pharma ED Treatment Product and Services
2.8.4 Metuchen Pharma ED Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Seoul Pharma
2.9.1 Seoul Pharma Details
2.9.2 Seoul Pharma Major Business
2.9.3 Seoul Pharma ED Treatment Product and Services
2.9.4 Seoul Pharma ED Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 CSBIO.
2.10.1 CSBIO. Details
2.10.2 CSBIO. Major Business
2.10.3 CSBIO. ED Treatment Product and Services
2.10.4 CSBIO. ED Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 ED Treatment Sales by Manufacturer
3.1 Global ED Treatment Sales in Volume by Manufacturer (2019-2021e)
3.2 Global ED Treatment Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in ED Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 ED Treatment Manufacturer Market Share
3.4.2 Top 6 ED Treatment Manufacturer Market Share
3.5 Global ED Treatment Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and ED Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global ED Treatment Market Size by Region
4.1.1 Global ED Treatment Sales in Volume by Region (2016-2026)
4.1.2 Global ED Treatment Revenue by Region (2016-2026)
4.2 North America ED Treatment Revenue (2016-2026)
4.3 Europe ED Treatment Revenue (2016-2026)
4.4 Asia-Pacific ED Treatment Revenue (2016-2026)
4.5 South America ED Treatment Revenue (2016-2026)
4.6 Middle East and Africa ED Treatment Revenue (2016-2026)
5 Market Segment by Type
5.1 Global ED Treatment Sales in Volume by Type (2016-2026)
5.2 Global ED Treatment Revenue by Type (2016-2026)
5.3 Global ED Treatment Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global ED Treatment Sales in Volume by Application (2016-2026)
6.2 Global ED Treatment Revenue by Application (2016-2026)
6.3 Global ED Treatment Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America ED Treatment Sales by Type (2016-2026)
7.2 North America ED Treatment Sales by Application (2016-2026)
7.3 North America ED Treatment Market Size by Country
7.3.1 North America ED Treatment Sales in Volume by Country (2016-2026)
7.3.2 North America ED Treatment Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe ED Treatment Sales by Type (2016-2026)
8.2 Europe ED Treatment Sales by Application (2016-2026)
8.3 Europe ED Treatment Market Size by Country
8.3.1 Europe ED Treatment Sales in Volume by Country (2016-2026)
8.3.2 Europe ED Treatment Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific ED Treatment Sales by Type (2016-2026)
9.2 Asia-Pacific ED Treatment Sales by Application (2016-2026)
9.3 Asia-Pacific ED Treatment Market Size by Region
9.3.1 Asia-Pacific ED Treatment Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific ED Treatment Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America ED Treatment Sales by Type (2016-2026)
10.2 South America ED Treatment Sales by Application (2016-2026)
10.3 South America ED Treatment Market Size by Country
10.3.1 South America ED Treatment Sales in Volume by Country (2016-2026)
10.3.2 South America ED Treatment Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa ED Treatment Sales by Type (2016-2026)
11.2 Middle East & Africa ED Treatment Sales by Application (2016-2026)
11.3 Middle East & Africa ED Treatment Market Size by Country
11.3.1 Middle East & Africa ED Treatment Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa ED Treatment Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 ED Treatment Typical Distributors
12.3 ED Treatment Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global ED Treatment Revenue by Type, (USD Million), 2021-2026
Table 2. Global ED Treatment Revenue by Application, (USD Million), 2021-2026
Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly Major Business
Table 5. Eli Lilly ED Treatment Product and Services
Table 6. Eli Lilly ED Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer ED Treatment Product and Services
Table 10. Pfizer ED Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer ED Treatment Product and Services
Table 14. Bayer ED Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. BaiYunShan General Factory Basic Information, Manufacturing Base and Competitors
Table 16. BaiYunShan General Factory Major Business
Table 17. BaiYunShan General Factory ED Treatment Product and Services
Table 18. BaiYunShan General Factory ED Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. S.K. Chemicals Basic Information, Manufacturing Base and Competitors
Table 20. S.K. Chemicals Major Business
Table 21. S.K. Chemicals ED Treatment Product and Services
Table 22. S.K. Chemicals ED Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Teva Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharma Major Business
Table 25. Teva Pharma ED Treatment Product and Services
Table 26. Teva Pharma ED Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Dong-A ST Basic Information, Manufacturing Base and Competitors
Table 28. Dong-A ST Major Business
Table 29. Dong-A ST ED Treatment Product and Services
Table 30. Dong-A ST ED Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Metuchen Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Metuchen Pharma Major Business
Table 33. Metuchen Pharma ED Treatment Product and Services
Table 34. Metuchen Pharma ED Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Seoul Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Seoul Pharma Major Business
Table 37. Seoul Pharma ED Treatment Product and Services
Table 38. Seoul Pharma ED Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. CSBIO. Basic Information, Manufacturing Base and Competitors
Table 40. CSBIO. Major Business
Table 41. CSBIO. ED Treatment Product and Services
Table 42. CSBIO. ED Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global ED Treatment Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global ED Treatment Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in ED Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global ED Treatment Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and ED Treatment Production Site of Key Manufacturer
Table 48. Global ED Treatment Sales by Region (2016-2021e) & (K Units)
Table 49. Global ED Treatment Sales by Region (2021-2026) & (K Units)
Table 50. Global ED Treatment Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global ED Treatment Revenue by Region (2021-2026) & (USD Million)
Table 52. Global ED Treatment Sales by Type (2016-2021e) & (K Units)
Table 53. Global ED Treatment Sales by Type (2021-2026) & (K Units)
Table 54. Global ED Treatment Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global ED Treatment Revenue by Type (2021-2026) & (USD Million)
Table 56. Global ED Treatment Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global ED Treatment Price by Type (2021-2026) & (USD/Unit)
Table 58. Global ED Treatment Sales by Application (2016-2021e) & (K Units)
Table 59. Global ED Treatment Sales by Application (2021-2026) & (K Units)
Table 60. Global ED Treatment Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global ED Treatment Revenue by Application (2021-2026) & (USD Million)
Table 62. Global ED Treatment Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global ED Treatment Price by Application (2021-2026) & (USD/Unit)
Table 64. North America ED Treatment Sales by Country (2016-2021e) & (K Units)
Table 65. North America ED Treatment Sales by Country (2021-2026) & (K Units)
Table 66. North America ED Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America ED Treatment Revenue by Country (2021-2026) & (USD Million)
Table 68. North America ED Treatment Sales by Type (2016-2021e) & (K Units)
Table 69. North America ED Treatment Sales by Type (2021-2026) & (K Units)
Table 70. North America ED Treatment Sales by Application (2016-2021e) & (K Units)
Table 71. North America ED Treatment Sales by Application (2021-2026) & (K Units)
Table 72. Europe ED Treatment Sales by Country (2016-2021e) & (K Units)
Table 73. Europe ED Treatment Sales by Country (2021-2026) & (K Units)
Table 74. Europe ED Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe ED Treatment Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe ED Treatment Sales by Type (2016-2021e) & (K Units)
Table 77. Europe ED Treatment Sales by Type (2021-2026) & (K Units)
Table 78. Europe ED Treatment Sales by Application (2016-2021e) & (K Units)
Table 79. Europe ED Treatment Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific ED Treatment Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific ED Treatment Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific ED Treatment Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific ED Treatment Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific ED Treatment Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific ED Treatment Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific ED Treatment Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific ED Treatment Sales by Application (2021-2026) & (K Units)
Table 88. South America ED Treatment Sales by Country (2016-2021e) & (K Units)
Table 89. South America ED Treatment Sales by Country (2021-2026) & (K Units)
Table 90. South America ED Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America ED Treatment Revenue by Country (2021-2026) & (USD Million)
Table 92. South America ED Treatment Sales by Type (2016-2021e) & (K Units)
Table 93. South America ED Treatment Sales by Type (2021-2026) & (K Units)
Table 94. South America ED Treatment Sales by Application (2016-2021e) & (K Units)
Table 95. South America ED Treatment Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa ED Treatment Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa ED Treatment Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa ED Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa ED Treatment Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa ED Treatment Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa ED Treatment Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa ED Treatment Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa ED Treatment Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. ED Treatment Typical Distributors
Table 107. ED Treatment Typical Customers
List of Figures
Figure 1. ED Treatment Picture
Figure 2. Global ED Treatment Sales Market Share by Type in 2020
Figure 3. Sildenafil
Figure 4. Tadalafil
Figure 5. Others
Figure 6. Global ED Treatment Sales Market Share by Application in 2020
Figure 7. Hospitals
Figure 8. Drugstores
Figure 9. Other
Figure 10. Global ED Treatment Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global ED Treatment Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey ED Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global ED Treatment Sales (2016-2026) & (K Units)
Figure 32. Global ED Treatment Production Capacity (2016-2026) & (K Units)
Figure 33. Global ED Treatment Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. ED Treatment Market Drivers
Figure 35. ED Treatment Market Restraints
Figure 36. ED Treatment Market Trends
Figure 37. Global ED Treatment Sales Market Share by Manufacturer in 2020
Figure 38. Global ED Treatment Revenue Market Share by Manufacturer in 2020
Figure 39. ED Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 ED Treatment Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 ED Treatment Manufacturer (Revenue) Market Share in 2020
Figure 42. Global ED Treatment Sales Market Share by Region (2016-2026)
Figure 43. Global ED Treatment Revenue Market Share by Region (2016-2026)
Figure 44. North America ED Treatment Revenue (2016-2026) & (USD Million)
Figure 45. Europe ED Treatment Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific ED Treatment Revenue (2016-2026) & (USD Million)
Figure 47. South America ED Treatment Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa ED Treatment Revenue (2016-2026) & (USD Million)
Figure 49. Global ED Treatment Sales Market Share by Type (2016-2026)
Figure 50. Global ED Treatment Revenue Market Share by Type (2016-2026)
Figure 51. Global ED Treatment Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global ED Treatment Sales Market Share by Application (2016-2026)
Figure 53. Global ED Treatment Revenue Market Share by Application (2016-2026)
Figure 54. Global ED Treatment Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America ED Treatment Sales Market Share by Country (2016-2026)
Figure 56. North America ED Treatment Revenue Market Share by Country (2016-2026)
Figure 57. North America ED Treatment Sales Market Share by Type (2016-2026)
Figure 58. North America ED Treatment Sales Market Share by Application (2016-2026)
Figure 59. Europe ED Treatment Sales Market Share by Country (2016-2026)
Figure 60. Europe ED Treatment Revenue Market Share by Country (2016-2026)
Figure 61. Europe ED Treatment Sales Market Share by Type (2016-2026)
Figure 62. Europe ED Treatment Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific ED Treatment Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific ED Treatment Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific ED Treatment Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific ED Treatment Sales Market Share by Application (2016-2026)
Figure 67. South America ED Treatment Sales Market Share by Country (2016-2026)
Figure 68. South America ED Treatment Revenue Market Share by Country (2016-2026)
Figure 69. South America ED Treatment Sales Market Share by Type (2016-2026)
Figure 70. South America ED Treatment Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa ED Treatment Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa ED Treatment Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa ED Treatment Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa ED Treatment Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
クラッベ病治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…- 第IX因子不足治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. Scope of the Report: This report studies the Factor IX Deficiency Treatment market status and outlook of Global and major regio…
- 薬物乱用の治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Substance abuse has become a major cause of concern. People are increasingly getting addicted to a variety of drugs, affecting their health and their family life to a large extent. With prolonged drug and alcohol abuse, the prevalence of mental illness and various chronic diseases, such as diabetes …
- 乳糖不耐症の治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Lactose intolerance cause symptoms such as abdominal pain, bloating, diarrhoea, gas, nausea etc. due to the decreased ability to digest the sugar lactose in milk products. Lactose intolerance is caused due to the lack of enzyme lactase which breaks lactose into glucose and galactose. Scope of the Re…
- 高カルシウム血症治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hypercalcemia is a condition caused by above normal levels of calcium in the body, with serum calcium level greater than 2.6 mmol/L. It is a life threatening metabolic disorder associated with neoplastic diseases and occurs in 10% to 20% of all adults suffering from cancer; particularly lung and bre…